SECsense Logo

Assembly Biosciences, Inc. 8-K Report: Key Insights from December 2024 Filing

$ASMB
Form 8-K
Filed on: 2024-12-26
Source
Assembly Biosciences, Inc. 8-K Report: Key Insights from December 2024 Filing

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Assembly Biosciences, Inc.
  • CIK: 0001426800
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-35005
  • EIN: 20-8729264
  • Address: Two Tower Place, 7th Floor, South San Francisco, CA 94080
  • Contact Number: (833) 509-4583
  1. Report Type and Date:
  • Report Type: Form 8-K
  • Report Date: December 26, 2024
  1. Stock Information:
  • Common Stock: Par value of $0.001
  • Ticker Symbol: ASMB
  • Exchange: NASDAQ
  1. Period of Reporting:
  • Reporting Period: The start and end date for the report is December 26, 2024.
  1. XBRL and Schema Reference:
  • The report is formatted in XBRL (eXtensible Business Reporting Language) for structured data reporting.
  • Schema Reference: The report references the schema file asmb-20241226.xsd.

Summary:

This section of the financial report indicates that Assembly Biosciences, Inc. filed an 8-K report on December 26, 2024, detailing information relevant to its common stock and other corporate updates. The data is structured in XBRL format, making it easier for analysts to extract and analyze the information. The report identifies key corporate and stock-related details which are essential for investors and stakeholders to understand the company's regulatory disclosures.